Due to the high rates of recurrence following initial therapy and the short overall survival times of individuals with BPDCN, prognosis of the disease is poor. However, further study of treatment regimens that include intrathecal chemotherapy and hematological stem cell transplantation in initial treatment regimens (see previous section) and newer non-chemotherapeutic drug treatments (see next section) may improve this situation.
Blastic plasmacytoid dendritic cell neoplasm
Congenital self-healing reticulohistiocytosis
Nodal marginal zone B cell lymphoma
Angioimmunoblastic T-cell lymphoma
Mature T-cell lymphoma
Peripheral T-cell lymphoma
Precursor T-lymphoblastic lymphoma
Pleomorphic T-cell lymphoma